SEC Form 4 · accession 0001209191-16-151999
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Petrus Bekker
Officer — Chief Medical Officer
Period of report
Nov 22, 2016
Accepted (ET)
Nov 23, 2016 · 6:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 22, 2016 | M | 1,250 | $6.30 | A | 54,844 | D | |
| Common Stock | Nov 22, 2016 | S | 1,250 | $8.30 | D | 53,594 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F2 | $6.30 | Nov 22, 2016 | M | 1,250 | D | Aug 10, 2010 | Aug 10, 2020 | Common Stock | 1,250 | 47,760 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2As of November 22, 2016 and prior to this transaction, the option fully vested
- F3Not applicable.